Before You Go
- Date: Saturday, May 5, 2018
- Location: 117 West 46th Street, New York City
- Register here
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.